In conclusion, we found high prevalence of T allele of MUC5B gene in patients with IPF; however, it showed no influence on disease trajectory, survival, or antifibrotic treatment effect in the presented cohort. This evidence concerns the gene MUC5B and idiopathic pulmonary fibrosis.